News and Insights of 3D Printing and Manufacturing
Aprecia Pharmaceuticals, the company behind the first FDA approved 3D printed drug Spritam, has entered into a long-term collaboration with private non-profit research and development (R&D) firm, Battelle.
Aprecia Pharmaceuticals, the company behind the first FDA approved 3D printed drug Spritam, has announced a partnership with Purdue University’s College of Pharmacy to advance the technology and science of 3D pharmaceutical printing. Their collaboration will focus on developing future 3D printed pharmaceutical equipment and medications.